Prediction of Optimal Reversal Dose of Sugammadex after Rocuronium Administration in Adult Surgical Patients

الملخص EN

The objective of this study was to determine the point after sugammadex administration at which sufficient or insufficient dose could be determined, using first twitch height of train-of-four (T1 height) or train-of-four ratio (TOFR) as indicators.

Groups A and B received 1 mg/kg and 0.5 mg/kg of sugammadex, respectively, as a first dose when the second twitch reappeared in train-of-four stimulation, and Groups C and D received 1 mg/kg and 0.5 mg/kg of sugammadex, respectively, as the first dose at posttetanic counts 1–3.

Five minutes after the first dose, an additional 1 mg/kg of sugammadex was administered and changes in T1 height and TOFR were observed.

Patients were divided into a recovered group and a partly recovered group, based on percentage changes in T1 height after additional dosing.

T1 height and TOFR during the 5 min after first dose were then compared.

In the recovered group, TOFR exceeded 90% in all patients at 3 min after sugammadex administration.

In the partly recovered group, none of the patients had a TOFR above 90% at 3 min after sugammadex administration.

An additional dose of sugammadex can be considered unnecessary if the train-of-four ratio is ≥90% at 3 min after sugammadex administration.

This trial is registered with UMIN000007245.